Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Northview Acquisition's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Northview Acquisition (NVAC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
5
Publicly traded peers
Peer Group Market Share
-
Share of combined sales, Q2 2026
Revenue Growth Y/Y
-
Peers: -22.63 %
Net Margin
-
Peers: 27.30 %

Key Findings: Northview Acquisition vs Its Competitors

  • TTM: Trailing 12-month revenue of 7M vs 12,178M combined for tracked competitors (0.1% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-328.3% annualized vs trailing 12 months), vs decelerating (-22.1%) for its tracked peer group.
  • Peer differentiation: Revenue per employee of $0.04M compares with $1.27M for the peer group (0.0x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/NVAC/competitors
https://api.csimarket.com/api/v1/companies/NVAC/relationships
https://api.csimarket.com/api/v1/companies/NVAC/similar
Programmatic access for models, analytics, and integration workflows.

Northview Acquisition vs. its Competitors, Q2 2026

Revenue run-rate vs trailing 12 months

Northview Acquisition -328.3 %
Competitors combined -22.1 %

TTM net margin

Northview Acquisition -357.3 %
Competitors combined +28.6 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Northview Acquisition and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Northview Acquisition Corp $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
High-Confidence Competitors (4) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Northview Acquisition's competitor groups requires a Commercial License.

Northview Acquisition's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Northview Acquisition Corp - - - No
Competitors combined (5) 100% 50% 0% 60%
High-Confidence Competitors (6) 60% 100% 80% 20%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

NVAC Stock Performance relative to its Competitors

NVAC Competitors (weighted) Percent change over the selected range

Northview Acquisition's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Competitors Combined
(0 of 4)
40%beat U.S.A. 500
High-Confidence
(2 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Northview Acquisition Corp 26.50 % Outperformed
Competitors combined (4) 40.4% 63.2%
High-Confidence Competitors (5) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Northview Acquisition's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

NVAC Stock Performance relative to High-Confidence Competitors

NVAC High-Confidence Competitors (equal-weighted, 6) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 American Homes 4 Rent 282.9% Outperformed
2 Invitation Homes Inc 282.9% Outperformed
3 Camden Property Trust 282.9% Outperformed
4 Avalonbay Communities inc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Northview Acquisition's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Northview Acquisition's Comment on Competition and Industry Peers

Profusa's Lumee Oxygen and Lumee Glucose sensing systems operate in a competitive market with multiple companies providing real-time biochemical data devices. Lumee Oxygen is positioned to complement angiographic and computer tomographic technologies and competes with digital subtraction angiography devices from Philips, CT devices from Siemens Healthineers, and transcutaneous oximetry devices from Perimed AB, Radiometer Medical, and SenTec AG. It also competes with doppler or cuff devices measuring Ankle-Brachial Index, Toe-Brachial Index, Segmental Pressure Values, and Pulse Volume Recording, as well as experimental Near-Infrared Spectroscopy methods. Lumee Glucose competes in the personal use segment with Continuous Glucose Monitoring technologies from Dexcom, Abbott, Medtronic, Senseonics, Diamontech, Movano, and Nemaura Medical, targeting patients with Type 1 and Type 2 diabetes and pre-diabetics. In the professional use segment, Lumee Glucose competes with technologies from Dexcom, Abbott, and Medtronic. Profusa expects that emerging noninvasive technologies, such as wristbands or smartwatches, may influence the competitive landscape in the future.

Publicly Traded Peers of Northview Acquisition Corp

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Northview Acquisition Corp 69.79 7.45 -26.60 180
Equity Residential 24,437.67 3,030.82 899.21 1,600
Invitation Homes Inc 15,600.47 2,855.08 662.98 1,725
American Homes 4 Rent 10,964.96 1,862.98 542.82 1,598
Camden Property Trust 9,901.57 1,346.24 336.62 1,640
Avalonbay Communities inc 9,664.62 3,082.70 1,035.33 3,041
SUBTOTAL 70,639.08 12,185.26 3,450.34 9,784

Sources: Northview Acquisition Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Northview Acquisition Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Northview Acquisition's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
SenTec AG Named by the company 85% 2022 to 2026 3
Medtronic Named by the company 85% 2022 to 2026 3
Radiometer Medical Named by the company 85% 2022 to 2026 3
Dexcom Named by the company 85% 2022 to 2026 3
Perimed AB Named by the company 85% 2022 to 2026 3
Siemens Healthineers Named by the company 85% 2022 to 2026 3
Movano Named by the company 85% 2022 to 2026 3
Senseonics Named by the company 85% 2022 to 2026 3
Diamontech Named by the company 85% 2022 to 2026 3
Philips Named by the company 85% 2022 to 2026 3
Abbott Named by the company 85% 2022 to 2026 3
Nemaura Medical Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Northview Acquisition's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Northview Acquisition's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Northview Acquisition Corp 70 41,371 -147,801
Equity Residential 24,438 1,894,260 562,004
Invitation Homes Inc 15,600 1,655,118 384,334
American Homes 4 Rent 10,965 1,165,821 339,686
Camden Property Trust 9,902 820,880 205,254
Avalonbay Communities inc 9,665 1,013,712 340,457
PEERS TOTAL 70,569 1,267,994 362,031

Northview Acquisition's Position in Industry Market Structure

Market-capitalization share and concentration across all 222 companies in Northview Acquisition's industry classification, broader than the peer set above. Market cap in millions of $.

Northview Acquisition ranks #0 of 222 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 584, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Intuitive Surgical Inc 145,289 13.39 %
2 Medtronic Plc 110,891 10.22 %
3 Stryker Corp 106,301 9.80 %
4 3m Company 85,752 7.91 %
5 Boston Scientific Corporation 1,234 5.2%
6 Edwards Lifesciences Corporation 1,234 5.2%
7 Becton Dickinson And Company 1,234 5.2%
8 Dexcom Inc 1,234 5.2%
9 Resmed Inc 1,234 5.2%
10 Alcon inc 1,234 5.2%
0 Northview Acquisition Corp 21 0.00 %
Full Industry Market Structure

Market cap and industry share for the rest of Northview Acquisition's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2025-06-04.

Northview Acquisition's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 2021202220242025
Revenue Growth ----
Operating Margin ----
Return on Invested Capital --0.66 %43.40 %18.44 %
P/E ----

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Northview Acquisition's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry High Industry HHI of 584 (see Industry Market Structure & Concentration above)
Supplier Power Not covered on this page See Northview Acquisition's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Northview Acquisition's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Northview Acquisition's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Return on equity 112.2 points above the industry aggregate.
  • Outperforming the U.S.A. 500 over the trailing 12 months.

Weaknesses

  • Latest-quarter revenue run-rate is decelerating (-328.3% annualized vs trailing 12 months).

Opportunities

  • A meaningful share of tracked competitors (60.00 %) show financial-distress signals, a possible opening to gain share.

Threats

  • Tracked peer group's revenue run-rate is broadly decelerating (-22.1% annualized).

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Northview Acquisition's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Northview Acquisition Corp 0.15 0.06 - 3.90
Equity Residential 0.08 0.08 0.42 0.15
Invitation Homes Inc 0.40 0.49 0.53 0.15
American Homes 4 Rent 0.14 0.23 0.63 0.14
Camden Property Trust 0.07 4.47 0.82 0.15
Avalonbay Communities inc 0.21 0.44 0.25 0.14

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Northview Acquisition's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Northview Acquisition CorpQ2 2026----
Equity ResidentialQ2 2026-10.7 %-12.0 %-40.8 %+26.5 %
Invitation Homes Inc Q2 2026+9.7 %+1.8 %+55.4 %+36.4 %
American Homes 4 RentQ2 2026--+7.5 %-10.7 %
Camden Property TrustQ2 2026-59.7 %-58.8 %-74.9 %-53.3 %
Avalonbay Communities inc Q2 2026+2.3 %+1.0 %-41.9 %-52.2 %
PEERS TOTAL-22.8 %-24.7 %-21.4 %-17.2 %

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Northview Acquisition's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Northview Acquisition CorpQ2 2026+3,602.0 %+3,916.7 %-+1,360.0 %
Equity ResidentialQ2 2026+4.8 %-4.6 %-80.8 %-25.0 %
Invitation Homes Inc Q2 2026+37.4 %+15.6 %-67.9 %-10.5 %
American Homes 4 RentQ2 2026--0.0 %+66.5 %
Camden Property TrustQ2 2026+9.0 %+12.5 %+132.6 %+530.1 %
Avalonbay Communities inc Q2 2026+2.5 %-1.3 %-31.8 %-1.9 %

Northview Acquisition's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Northview Acquisition Corp-----
Equity Residential4.35%3.91%8.16%--
Invitation Homes Inc 3.55%3.27%7.08%--
American Homes 4 Rent4.11%4.02%7.09%38.57-
Camden Property Trust3.68%3.11%7.90%--
Avalonbay Communities inc 4.68%4.57%8.64%-8.60

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Northview Acquisition's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Northview Acquisition Corp-9.37-132.74-
Equity Residential27.688.06--2.28
Invitation Homes Inc 24.265.460.60358.151.72
American Homes 4 Rent24.105.891.43-1.47
Camden Property Trust32.147.350.18698.522.55
Avalonbay Communities inc 20.533.141.33-0.79
PEERS AVERAGE20.475.80-1.63

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.

Get the full CSIMarket dataset: Subscribe API License